PHILADELPHIA, Pennsylvania, March 16, 2010 /PRNewswire/ -- Elsevier, a world-leading publisher of scientific, technical, and medical information products and services, announced today that Prof. Maurice Courbage and Prof. Paolo Grigolini (University of North Texas, USA) have been appointed as the new Co-Editors-in-Chief of Chaos, Solitons Fractals [ http://www.elsevier.com/wps/find/journaldescription.cws_home/967/descrip... description]
(Due to the length of this URL, it may be necessary to copy and paste the hyperlinks into your Internet browser's URL address field. Remove the space if one exists.)
Prof. Courbage works in the Theory of Complex Systems research group of the Universite Denis Diderot - Paris 7. His research interests include nonlinear science and complexity, including quantum and classical statistical mechanics, neurodynamics, ergodic theory and cellular automata. Prof. Grigolini is a member of the Center for Nonlinear Science at the University of Texas where he works on quantum mechanics, statistical physics, complex networks and biological systems, in particular the complexity in neurophysiological processes.
In addition to the two new co-Editors-in-Chief, Chaos, Solitons Fractals has refined its Aims Scope, which now center on the interdisciplinary theme of complexity. The journal has also undergone some changes in the editorial structure. Regular articles, letters and reviews, as well as Frontiers papers, up-to-date overviews of a particular field, will be the main article types throughout the journal. The journal also has a new look, including the cover and will be published in two column formatting. Submissions will be accepted shortly at http://ees.elsevier.com/chaos/.
It is our ambition to develop Chaos, Solitons Fractals into a leading journal in the exciting field of complexity, commented Prof. Grigolini.
Prof. Courbage added, One of the main hallmarks of the journal will be the interdisciplinarity of complex systems. We are pleased to be joined by some excellent editorial board members, who will be instrumental in attracting leading authors in the field.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (http://www.thelancet.com) and Cell (http://www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (http://www.sciencedirect.com), Scopus (http://www.scopus.com), Reaxys (http://www.reaxys.com), MD Consult (http://www.mdconsult.com) and Nursing Consult (http://www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (http://www.scival.com) and MEDai's Pinpoint Review (http://www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier ( http://www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (http://www.reedelsevier.com), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Tom Reller Elsevier +1-215-239-3508 t.reller@elsevier.com
SOURCE: Elsevier
CONTACT: Tom Reller, Elsevier, +1-215-239-3508, t.reller@elsevier.com
Comments